Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft versus Host Disease
Clinical Trial Grant
Duke Scholars
Principal Investigator
Chenyu Lin
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
Incyte Corporation
Start Date
July 31, 2024
End Date
July 30, 2029
Awarded By
Incyte Corporation
Start Date
July 31, 2024
End Date
July 30, 2029
